VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 03/26/12 -- Response Biomedical Corporation (TSX:RBM)(OTCBB:RPBIF) will release its fourth quarter and fiscal year 2011 financial results after markets close on Wednesday, March 28, 2012.
Dr. Peter A. Thompson, Executive Chairman and interim CEO, will host a conference call shortly following the release of the financial results on March 28, 2012 at 3.00 p.m. PST (6.00 p.m. EST) to discuss these financial results for the fourth quarter and fiscal year 2011.
Conference Call Details
The conference dial in numbers are:
North America: (877) 643-7155
International: (914) 495-8552
Conference ID: 66118248
A live audio webcast of the call will be available in the Investor Relations section of the Response Biomedical website: Response Biomedical - Newsroom - Events Calendar: Corporate: http://www.responsebio.com/newsroom_events_calendar_corporate.asp?menu=1&submenu=2. A replay of the conference call will also be available there approximately two hours after the call and for 90 days thereafter.
About Response Biomedical
Response Biomedical develops, manufactures and markets rapid on-site diagnostic tests for use with its RAMP® platform for clinical and environmental applications. RAMP® represents a new paradigm in diagnostics that provides high sensitivity and reliable information in minutes. It is ideally suited to both point of care testing and laboratory use.
The RAMP® system consists of a reader and single-use disposable test cartridges, and has the potential to be adapted to more than 250 medical and non-medical tests currently performed in laboratories.